AJP - Renal Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 285: F95-F104, 2003. First published March 18, 2003; doi:10.1152/ajprenal.00396.2002
0363-6127/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/1/F95    most recent
00396.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gui, Y.
Right arrow Articles by Hollenberg, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gui, Y.
Right arrow Articles by Hollenberg, M. D.

Bidirectional regulation of renal hemodynamics by activation of PAR1 and PAR2 in isolated perfused rat kidney

Yu Gui,1 Rodger Loutzenhiser,1 and Morley D. Hollenberg1,2

Canadian Institutes of Health Group on the Regulation of Vascular Contractility, Smooth Muscle Research Group, Departments of 1Pharmacology and Therapeutics and 2Medicine, University of Calgary, Calgary, Alberta, Canada T2N 4N1

Submitted 6 November 2002 ; accepted in final form 11 March 2003

Proteinase-activated receptors (PARs) are activated by either serine proteinases or synthetic peptides corresponding to the NH2-terminal tethered ligand sequences that are unmasked by proteolytic cleavage. Although PARs are highly expressed in the kidney, their roles in regulating renal function are not known. In the present study, we evaluated the impact of PAR activation on renal hemodynamics using PAR1- and PAR2-activating peptides (TFLLR-NH2 and SLIGRL-NH2) and proteinases (thrombin and trypsin) as PAR agonists in the isolated perfused rat kidney preparation. PAR1 activation resulted in renal vasoconstriction and a marked reduction in the glomerular filtration rate (GFR). In contrast, PAR2 activation caused vasodilation, partially reversing the vasoconstriction induced by TFLLR-NH2 and ANG II and increasing GFR that had been prereduced by ANG II. The vasoconstrictor actions of PAR1 activation were abolished by protein kinase C inhibition. The PAR2-induced vasodilation was only partially blocked by NG-nitro-L-arginine methyl ester, suggesting both nitric oxide-dependent and -independent mechanisms. Although PAR4 mRNA was detected in renal parenchyma, the PAR4-activating peptide AYPGKF-NH2 had no effect on renal perfusion flow rate. We conclude that PAR1 and PAR2 play bidirectional roles in the regulation of renal hemodynamics.

nitric oxide; trypsin; thrombin; endothelium-derived relaxing factor; glomerular filtration rate



Address for reprint requests and other correspondence: M. D. Hollenberg, Dept. of Pharmacology and Therapeutics and Dept. of Medicine, Univ. of Calgary, Faculty of Medicine, 3330 Hospital Drive NW, Calgary, AB, Canada T2N 4N1 (E-mail: mhollenb{at}ucalgary.ca).




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
D. A. Vesey, W. A. Kruger, P. Poronnik, G. C. Gobe, and D. W. Johnson
Proinflammatory and proliferative responses of human proximal tubule cells to PAR-2 activation
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1441 - F1449.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. Nitescu, E. Grimberg, S.-E. Ricksten, N. Marcussen, H. Nordlinder, and G. Guron
Effects of thrombin inhibition with melagatran on renal hemodynamics and function and liver integrity during early endotoxemia
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1117 - R1124.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
X. Wang, J. Breaks, K. Loutzenhiser, and R. Loutzenhiser
Effects of inhibition of the Na+/K+/2Cl- cotransporter on myogenic and angiotensin II responses of the rat afferent arteriole
Am J Physiol Renal Physiol, March 1, 2007; 292(3): F999 - F1006.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Sevastos, S. E. Kennedy, D. R. Davis, M. Sam, P. W. Peake, J. A. Charlesworth, N. Mackman, and J. H. Erlich
Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury
Blood, January 15, 2007; 109(2): 577 - 583.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Ayala, D. J. Warejcka, M. Olague-Marchan, and S. S. Twining
Corneal Activation of Prothrombin to Form Thrombin, Independent of Vascular Injury
Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 134 - 143.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
X. Wang, M. D. Hollenberg, and R. Loutzenhiser
Redundant signaling mechanisms contribute to the vasodilatory response of the afferent arteriole to proteinase-activated receptor-2
Am J Physiol Renal Physiol, January 1, 2005; 288(1): F65 - F75.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Kawabata, S. Kubo, Y. Nakaya, T. Ishiki, R. Kuroda, F. Sekiguchi, N. Kawao, and H. Nishikawa
Distinct roles for protease-activated receptors 1 and 2 in vasomotor modulation in rat superior mesenteric artery
Cardiovasc Res, March 1, 2004; 61(4): 683 - 692.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
X. Wang, G. Trottier, and R. Loutzenhiser
Determinants of renal afferent arteriolar actions of bradykinin: evidence that multiple pathways mediate responses attributed to EDHF
Am J Physiol Renal Physiol, September 1, 2003; 285(3): F540 - F549.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.